Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jan;15(1):29.
doi: 10.1007/s13205-024-04182-5. Epub 2025 Jan 2.

Shen Zhi Ling oral liquid improve neuroinflammation against Alzheimer's disease via the PI3K/Akt pathway

Affiliations

Shen Zhi Ling oral liquid improve neuroinflammation against Alzheimer's disease via the PI3K/Akt pathway

Gaofeng Qin et al. 3 Biotech. 2025 Jan.

Abstract

The etiology and pathogenesis of Alzheimer's disease (AD) are complex, and currently, no comprehensive treatment measures exist. In this study, we initially utilized ultra-high-performance liquid chromatography with quadrupole orbitrap mass spectrometry (UHPLC-QE-MS) to profile the bioactive constituents of SZLOL present in the bloodstream. Subsequent Y-maze experimental data demonstrated that SZLOL could ameliorate short-term memory deficits in APP/PS1 mice. Furthermore, micro-positron emission tomography (Micro-PET) experiments revealed that SZLOL enhanced glucose metabolism in the cerebral cortex of the mice. To model AD in vitro, we utilized Aβ42-induced SH-SY5Y cells and assessed the effects of SZLOL-containing serum on cell growth and migration using immunofluorescence and wound-healing assays. Both in vivo and in vitro Western blot analyses indicated that SZLOL and SZLOL-containing serum were capable of activating the PI3K/Akt signaling pathway, which modulates the expression of inflammatory mediators. In future studies, we will validate our findings in more animal and cell models.

Keywords: Alzheimer’s disease; Autophagy; Neuroinflammation; PI3K/Akt pathway; Shen Zhi Ling oral liquid.

PubMed Disclaimer

Conflict of interest statement

Conflict of interestThe authors declare no competing interests.

Similar articles

References

    1. Ali TB, Schleret TR, Reilly BM, Chen WY, Abagyan R (2015) Adverse effects of cholinesterase inhibitors in dementia, according to the pharmacovigilance databases of the United-States and Canada. PLoS ONE 10(12):e0144337 - PMC - PubMed
    1. Calsolaro V, Edison P (2016) Neuroinflammation in alzheimer’s disease: current evidence and future directions. AlzheimErs Dement 12(6):719–732 - PubMed
    1. Chainoglou E, Hadjipavlou-Litina DA-OX (2020) Curcumin in health and diseases: alzheimer’s disease and curcumin analogues, derivatives, and hybrids. LID 10.3390/ijms21061975. - PMC - PubMed
    1. Chen S, Peng J, Sherchan P, Ma Y, Xiang S, Yan F, Zhao H, Jiang Y, Wang N, Zhang JH, Zhang H (2020) TREM2 activation attenuates neuroinflammation and neuronal apoptosis via PI3K/Akt pathway after intracerebral hemorrhage in mice. J Neuroinflammation 1(17):168 - PMC - PubMed
    1. Chen S, Liu H, Wang S, Jiang H, Gao L, Wang L, Teng LA-O, Wang C, Wang D (2022) The neuroprotection of verbascoside in alzheimer’s disease mediated through mitigation of neuroinflammation via blocking NF-κB-p65 signaling. LID -. 10.3390/nu14071417 - PMC - PubMed

LinkOut - more resources